Chloe Kim Is Changing the Conversation Around ADHD in Women with Qelbree® for 'Ms. Represented' Campaign

What happened

Professional snowboarder Chloe Kim is sharing her adult ADHD diagnosis as a paid spokesperson for Supernus Pharmaceuticals' 'Ms. Represented' campaign for Qelbree, a once-a-day non-stimulant ADHD treatment for people ages 6 and older.

Confirmed

Global impact / market context

The campaign targets women, a group the article says is diagnosed less often than boys, which could widen the pool of potential Qelbree patients. For investors, that means the effort is a demand-building move for a Supernus product rather than a new clinical or regulatory event.

Analyst inference

The article cites a near doubling in newly diagnosed women ages 23–49 between 2020 and the following period, pointing to a growing patient group. Supernus is using a celebrity spokesperson to compete for attention in ADHD treatment, where perception of the condition shapes who seeks a diagnosis and asks about medication.

Analyst inference

What to watch

1. Chloe Kim is a paid spokesperson for Supernus and was diagnosed with ADHD as an adult, which the company is using to promote Qelbree through the 'Ms. Represented' campaign. Confirmed
2. Watch whether Supernus reports Qelbree prescription or sales trends in future updates, since the campaign aims to reach more women and could influence demand for the treatment. Proposed
3. If the campaign increases diagnosis and treatment conversations among women, Qelbree revenue could rise, but spending on the paid spokesperson and campaign adds costs that may offset near-term profit. Analyst inference

Evidence

• globenewswire.com